20 research outputs found
Minigene-like inhibition of protein synthesis mediated by hungry codons near the start codon
Rare AGA or AGG codons close to the initiation codon inhibit protein synthesis by a tRNA-sequestering mechanism as toxic minigenes do. To further understand this mechanism, a parallel analysis of protein synthesis and peptidyl-tRNA accumulation was performed using both a set of lacZ constructs where AGAAGA codons were moved codon by codon from +2, +3 up to +7, +8 positions and a series of 3ā8 codon minigenes containing AGAAGA codons before the stop codon. Ī²-Galactosidase synthesis from the AGAAGA lacZ constructs (in a Pth defective in vitro system without exogenous tRNA) diminished as the AGAAGA codons were closer to AUG codon. Likewise, Ī²-galactosidase expression from the reporter +7 AGA lacZ gene (plus tRNA, 0.25 Ī¼g/Ī¼l) waned as the AGAAGAUAA minigene shortened. Pth counteracted both the length-dependent minigene effect on the expression of Ī²-galactosidase from the +7 AGA lacZ reporter gene and the positional effect from the AGAAGA lacZ constructs. The +2, +3 AGAAGA lacZ construct and the shortest +2, +3 AGAAGAUAA minigene accumulated the highest percentage of peptidyl-tRNAArg4. These observations lead us to propose that hungry codons at early positions, albeit with less strength, inhibit protein synthesis by a minigene-like mechanism involving accumulation of peptidyl-tRNA
Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release.
Lipoxins and resolvins have anti-inflammatory and pro-resolving actions and accumulating evidence indicates that these lipid mediators also attenuate pain-like behavior in a number of experimental models of inflammation and tissue injury-induced pain. The present study was undertaken to assess if spinal administration of lipoxin A4 (LXA4) or 17 (R)-resolvin D1 (17(R)-RvD1) attenuates mechanical hypersensitivity in the carrageenan model of peripheral inflammation in the rat. Given the emerging role of spinal cytokines in the generation and maintenance of inflammatory pain we measured cytokine levels in the cerebrospinal fluid (CSF) after LXA4 or 17(R)-RvD1 administration, and the ability of these lipid metabolites to prevent stimuli-induced release of cytokines from cultured primary spinal astrocytes. We found that intrathecal bolus injection of LXA4 and17(R)-RvD1 attenuated inflammation-induced mechanical hypersensitivity without reducing the local inflammation. Furthermore, both LXA4 and 17(R)-RvD1 reduced carrageenan-induced tumor necrosis factor (TNF) release in the CSF, while only 17(R)-RvD1attenuated LPS and IFN-Ī³-induced TNF release in astrocyte cell culture. In conclusion, this study demonstrates that lipoxins and resolvins potently suppress inflammation-induced mechanical hypersensitivity, possibly by attenuating cytokine release from spinal astrocytes. The inhibitory effect of lipoxins and resolvins on spinal nociceptive processing puts them in an intriguing position in the search for novel pain therapeutics
17 (R)-RvD1 attenuate IFN-Ī³ and LPS induced TNF induction in rat primary astrocytes.
<p>Bar graphs showing levels of TNF in media from primary rat astrocyte cultures (A) following stimulation with IFN-Ī³ (1000 U/ml, 24 h), LPS (2 Āµg/ml, 24 h) or the combined effect of IFN-Ī³ (1000 U/ml, 4 h) followed by LPS (2 Āµg/ml, 20 h). Pretreatment with 17(R)-RvD1 (500 nM, 30 min) significantly reduced IFN-Ī³ (B) and LPS-induced (C)-TNF release. No significant effect was seen after pretreatment with LXA4 (500 nM, 30 min). Each bar represents mean Ā± S.E.M, * represents a significant difference at p<0.05 as compared to PBS (A) or indicated in the figure (B-D).</p
FPR2/ALX mRNA is present in the rat spinal cord and cultured spinal astrocytes.
<p>Bar graphs showing the expression of (A) FPR2/ALX mRNA in the rat ipsilateral spinal cord plotted versus time following carrageenan injection to the hind paw, presented as a percent of mRNA levels in control (naĆÆve) rat spinal cord. Each bar represents the mean Ā± S.E.M, n= 6-10. * represents a significant difference at p<0.05 as compared with naĆÆve spinal cord. FPR2/ALX mRNA is expressed in the rat (B) and human astrocytes (C). GPR32 mRNA is expressed in human astrocytes (C). mRNA levels are expressed as relative units and each bar represents the mean Ā± S.E.M for three repeats. The immunohistochemical images show the expression of FPR2/ALX (D), the astrocyte marker GFAP (E) and the colocalization of FPR2/ALX and GFAP (F) in naĆÆve rat lumbar spinal cord.</p
17(R)-RvD1 reduced TNF-induced ERK activation in human primary astrocytes.
<p>Bar graphs and representative western blots showing MAPK phosphorylation levels in control and TNF (50 ng/ml) stimulated cells. In astrocytes, 17(R)-RvD1 (265 nM) inhibited TNF-induced ERK (A), but not p38 (B) or JNK (C) phosphorylation. Each bar represents the mean Ā± S.E.M for three repeats. * represents p<0.05 for comparisons indicated in the figure.</p
Orthologs of a novel archaeal and of the bacterial peptidylātRNA hydrolase are nonessential in yeast
PeptidylātRNA hydrolase (encoded by pth) is an essential enzyme in all bacteria, where it releases tRNA from the premature translation termination product peptidylātRNA. Archaeal genomes lack a recognizable peptidylātRNA hydrolase (Pth) ortholog, although it is present in most eukaryotes. However, we detected Pth-like activity in extracts of the archaeon Methanocaldococcus jannaschii. The uncharacterized MJ0051 ORF was shown to correspond to a protein with Pth activity. Heterologously expressed MJ0051 enzyme catalyzed in vitro the cleavage of the Pth substrates diacetyl-[(14)C]lysylātRNA and acetyl-[(14)C]phenylalanylātRNA. On transformation of an Escherichia coli pth(ts) mutant, the MJ0051 gene (named pth2) rescued the temperature-sensitive phenotype of the strain. Analysis of known genomes revealed the presence of highly conserved orthologs of the archaeal pth2 gene in all archaea and eukaryotes but not in bacteria. The phylogeny of pth2 homologs suggests that the gene has been vertically inherited throughout the archaeal and eukaryal domains. Deletions in Saccharomyces cerevisiae of the pth2 (YBL057c) or pth (YHR189w) orthologs were viable, as was the double deletion strain, implying that the canonical Pth and Pth2 enzymes are not essential for yeast viability
Intrathecal injection of LXA4 and 17(R)-RvD1 reduces carrageenan-induced mechanical hypersensitivity.
<p>Paw withdrawal thresholds plotted versus time are shown for the ipsilateral (A, D) and contralateral (C, F) hind paw following carrageenan administration. Intrathecal pretreatment with LXA4 (A) or 17(R)-RvD1 (D) reduced mechanical hypersensitivity as compared to vehicle, while i.t. injection of LXA4 (C) or 17(R)-RvD1 (F) had no effect on mechanical thresholds in the contralateral (non-inflamed) hind paw. The hyperalgesic index (see material and methods) calculated for 0ā6 h was significantly reduced by LXA4 (B) and 17(R)-RvD1 (E) pretreatment. All data are presented as mean Ā± S.E.M, * represents a significant difference at p<0.05 as compared with i.t. vehicle.</p
Intrathecal injection of LXA4 and 17(R)-RvD1 does not change carrageenan-induced inflammation.
<p>Bar graphs show that the increased paw size measured 4 h following carrageenan injection was not altered by pretreatment with LXA4 (A) or 17(R)-RvD1 (B) as compared to pretreatment with vehicle. All data are presented as mean Ā± S.E.M, * represents a significant difference at p<0.05 as compared with i.t. vehicle.</p